Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

780.67
+1.390.18%
Post-market: 780.00-0.6700-0.09%16:58 EDT
Volume:1.45M
Turnover:1.13B
Market Cap:739.87B
PE:66.67
High:783.55
Open:780.46
Low:773.00
Close:779.28
Loading ...

Lilly Shares Down 1.2% Premarket

THOMSON REUTERS
·
17 Jun

Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash

TIPRANKS
·
17 Jun

Eli Lilly: CVR Holders Would Be Entitled to GET Contingent Payment Upon First Patient Being Dosed With Verve-102 for Ascvd in U.S. Phase 3 Trial

THOMSON REUTERS
·
17 Jun

Eli Lilly - Transaction Is Not Subject to Any Financing Condition

THOMSON REUTERS
·
17 Jun

Eli Lilly - Proposed Deal for Purchase Price of $10.50 per Share in Cash

THOMSON REUTERS
·
17 Jun

Trump Says Pharma Tariffs Coming Very Soon

Reuters
·
17 Jun

Verve Therapeutics Soars 82% Following Report of $1.3B Eli Lilly Takeover Talks

Tiger Newspress
·
17 Jun

Verve Therapeutics Shares Jump 69.7% to $10.6 Premarket After FT Reports Eli Lilly Nears $1.3 Bln Deal for Co

THOMSON REUTERS
·
17 Jun

Verve Therapeutics Stock Soars 75% as Eli Lilly Nears $1.3 Billion Deal for the Gene-Editing Biotech

Reuters
·
17 Jun

BRIEF-Eli Lilly Close To Buying Gene-Editing Biotech Verve Therapeutics - FT

Reuters
·
17 Jun

Eli Lilly Close to Buying Gene-Editing Biotech Verve Therapeutics- FT

THOMSON REUTERS
·
17 Jun

Eli Lilly & Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
17 Jun

Eli Lilly Stock (LLY) Sinks as Novo Nordisk Is Again Europe’s Most Valuable Company

TIPRANKS
·
17 Jun

BUZZ-Eli Lilly stock edges up as Zepbound doses expand on website

Reuters
·
17 Jun

Bernstein Remains a Buy on Eli Lilly & Co (LLY)

TIPRANKS
·
16 Jun

Lilly to offer higher dose versions of weight-loss drugs on website

Reuters
·
16 Jun

BRIEF-Lilly to Offer All Approved Zepbound Doses via LillyDirect Self-Pay Pharmacy

Reuters
·
16 Jun

Lilly to Offer All Approved Doses of Zepbound (Tirzepatide) Single-Dose Vials Through Lillydirect Self Pay Pharmacy Solutions

THOMSON REUTERS
·
16 Jun

Eli Lilly and Co - All Approved Zepbound Doses Available for $499/Month or Less

THOMSON REUTERS
·
16 Jun

Eli Lilly and Co - 12.5 Mg and 15 Mg Zepbound Vials Available for Prescription July 7

THOMSON REUTERS
·
16 Jun